Skip to content
Extreme Investor Network
  • Contact Us
  • Privacy Policy

biotech stock

Our #1 Biotech Stock for April

April 21, 2022April 1, 2022
Biotech Stocks

On September 10, 2018, a tiny Cambridge biotech firm won a patent on a new kind of genetic software that can “Cut & Paste” any disease from your body. This revolutionary new kind of treatment … Read more

Categories Stocks, Bonds, and Trading Tags biotech stock, genetic disease, investors, wall street journal

Categories

Recent Posts

  • Trump’s China Tariffs to Impact Ford, GM Vehicles and Auto ComponentsFebruary 5, 2025
  • Fed Officials Express Worries Over Trump’s Tariffs and Inflation IssuesFebruary 5, 2025
  • BlackRock Launches New ETFs Targeting $6 Trillion Money Market SectorFebruary 5, 2025
  • A ‘Set-It-and-Forget-It’ Investment Strategy Might Underperform in 2025February 5, 2025
  • Market Insights – February 5, 2025February 5, 2025
  • Satoshi Nakamoto’s Bitcoin Holdings Now Monitored on ArkhamFebruary 5, 2025
  • SoftBank Close to Finalizing Acquisition of Chip Designer AmpereFebruary 5, 2025
  • ETH/USD Tumbles 43% from All-Time High – Will the Pectra Upgrade Propel Ethereum back to $4K?February 5, 2025
  • CEO Lars Fruergaard Jorgensen Talks About WegovyFebruary 5, 2025
  • Can Zepbound’s Growth Meet Expectations?February 5, 2025

Archives

© 2025 Extreme Investor Network

Usermaven | Website analytics and product insights